Service Line:+1-315-239-3085
Address:FL-4, Building A5, International Enterprise Community, Tianjin, China
Email:info@kmdbioscience.com
Catalog Number | YR1096 |
---|---|
Product Name | Anti-Human FCER2 Recombinant Antibody |
Molecular Name | Lumiliximab |
Alias | Anti-FCER2 Recombinant Antibody, Research Grade Lumiliximab |
CAS Number | 357613-86-6 |
Molecular Weight | 47.75 kDa |
Target | FCER2[Homo sapiens] |
Isotype | IgG1 Kappa |
Clonity | Monoclonal |
Source | CHO Cells |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Purity | >95% as determined by SDS-PAGE |
Applications | IP, IF, FuncS, FCM, Neut, ELISA, ICC |
Buffer | PBS, pH7.5 |
Background | Lumiliximab is an IgG1k monoclonal antibody that targets CD23. It acts as an immunomodulator and was awarded orphan drug status and fast track designation by the FDA. |
Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Note | This product is for research use only. |